These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30765842)

  • 1. Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells.
    Cao YP; Sun JY; Li MQ; Dong Y; Zhang YH; Yan J; Huang RM; Yan X
    Acta Pharmacol Sin; 2019 Aug; 40(8):1076-1084. PubMed ID: 30765842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal overexpression of G9a in melanoma cells promotes cancer progression via upregulation of the Notch1 signaling pathway.
    Dang NN; Jiao J; Meng X; An Y; Han C; Huang S
    Aging (Albany NY); 2020 Feb; 12(3):2393-2407. PubMed ID: 32015216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone methyltransferase inhibitor UNC0642 promotes breast cancer cell death by upregulating TXNIP-dependent oxidative stress.
    Singh J; Sah B; Shen Y; Liu L
    Chem Biol Interact; 2023 Nov; 385():110720. PubMed ID: 37748637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.
    Fang T; Liu DD; Ning HM; Dan Liu ; Sun JY; Huang XJ; Dong Y; Geng MY; Yun SF; Yan J; Huang RM
    Acta Pharmacol Sin; 2018 Dec; 39(12):1885-1893. PubMed ID: 29769742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP.
    Liu F; Barsyte-Lovejoy D; Li F; Xiong Y; Korboukh V; Huang XP; Allali-Hassani A; Janzen WP; Roth BL; Frye SV; Arrowsmith CH; Brown PJ; Vedadi M; Jin J
    J Med Chem; 2013 Nov; 56(21):8931-42. PubMed ID: 24102134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of G9a inhibitor BIX‑01294 acting on U251 glioma cells.
    Guo AS; Huang YQ; Ma XD; Lin RS
    Mol Med Rep; 2016 Nov; 14(5):4613-4621. PubMed ID: 27748874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
    Yokoyama M; Chiba T; Zen Y; Oshima M; Kusakabe Y; Noguchi Y; Yuki K; Koide S; Tara S; Saraya A; Aoyama K; Mimura N; Miyagi S; Inoue M; Wakamatsu T; Saito T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Yokosuka O; Iwama A
    Oncotarget; 2017 Mar; 8(13):21315-21326. PubMed ID: 28423509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer's disease mouse model.
    Griñán-Ferré C; Marsal-García L; Bellver-Sanchis A; Kondengaden SM; Turga RC; Vázquez S; Pallàs M
    Aging (Albany NY); 2019 Dec; 11(23):11591-11608. PubMed ID: 31804189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma.
    Ren A; Qiu Y; Cui H; Fu G
    Biochem Biophys Res Commun; 2015 Mar; 459(1):10-7. PubMed ID: 25634693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.
    Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ
    Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
    Lin X; Huang Y; Zou Y; Chen X; Ma X
    Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the First-in-Class G9a/GLP PROTAC Degrader.
    Velez J; Han Y; Yim H; Yang P; Deng Z; Park KS; Kabir M; Kaniskan HÜ; Xiong Y; Jin J
    J Med Chem; 2024 Apr; 67(8):6397-6409. PubMed ID: 38602846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G9a inhibition potentiates the anti-tumour activity of DNA double-strand break inducing agents by impairing DNA repair independent of p53 status.
    Agarwal P; Jackson SP
    Cancer Lett; 2016 Oct; 380(2):467-475. PubMed ID: 27431310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
    Quan Y; Lei H; Wahafu W; Liu Y; Ping H; Zhang X
    Biomed Pharmacother; 2019 Dec; 120():109490. PubMed ID: 31574376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting H3K9 methyltransferase G9a and its related molecule GLP as a potential therapeutic strategy for cancer.
    Rahman Z; Bazaz MR; Devabattula G; Khan MA; Godugu C
    J Biochem Mol Toxicol; 2021 Mar; 35(3):e22674. PubMed ID: 33283949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and transcriptional inhibition of the G9a histone methyltransferase suppresses proliferation and modulates redox homeostasis in human microvascular endothelial cells.
    Wojtala M; Macierzyńska-Piotrowska E; Rybaczek D; Pirola L; Balcerczyk A
    Pharmacol Res; 2018 Feb; 128():252-263. PubMed ID: 29113759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
    Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
    Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a Highly Potent Lysine Methyltransferases G9a/NSD2 Dual Inhibitor to Treat Solid Tumors.
    Yang C; Li B; Feng Z; Li H; Yang H; Yang Z; Liu L; Shi Q; Wang H; Chen ZZ; Huang X; Wang J; Wang Y
    J Med Chem; 2024 Sep; 67(18):16072-16087. PubMed ID: 39008565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome.
    Kim Y; Lee HM; Xiong Y; Sciaky N; Hulbert SW; Cao X; Everitt JI; Jin J; Roth BL; Jiang YH
    Nat Med; 2017 Feb; 23(2):213-222. PubMed ID: 28024084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.